NCT04842942

Brief Summary

This is a single center, prospective case series designed to assess the safety and feasibility of TOETVA in a small cohort of patients at University Health Network Toronto. Included patients will undergo a TOETVA-procedure in stead of the standard open surgical procedure.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Dec 2019

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2019

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

February 19, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 13, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2022

Completed
Last Updated

April 13, 2021

Status Verified

April 1, 2021

Enrollment Period

2 years

First QC Date

February 19, 2021

Last Update Submit

April 11, 2021

Conditions

Keywords

TOETVATransoral Endoscopic Thyroidectomy Vestibular Approach

Outcome Measures

Primary Outcomes (11)

  • Post-operative recurrent laryngeal nerve palsy

    Number of participants with post-operative recurrent laryngeal nerve palsy

    12 months

  • Postoperative hypocalcemia

    Number of participants with postoperative hypocalcemia

    12 months

  • Neck incision

    Number of conversions to open

    1 month

  • Rate of oral infections

    Number of participants with oral infections

    12 months

  • Rate of hematoma

    Number of participants with hematomas

    1 month

  • Rate of seroma

    Number of participants with seromas

    1 month

  • Rate of neck infection

    Number of participants with neck infections

    12 months

  • Rate of subcutaneous emphysema

    Number of participants with subcutaneous emphysema

    12 months

  • Rate of gas-induced embolism

    Number of participants with gas-induced embolism

    12 months

  • Surgical time

    Surgical time in hours

    until surgical discharge, average of 24 hours

  • Length of stay

    Length of stay in days

    until surgical discharge, average of 24 hours

Secondary Outcomes (1)

  • Quality of Life Score

    12 months

Study Arms (1)

TOETVA

EXPERIMENTAL

Transoral Endoscopic Thyroidectomy Vestibular Approach

Procedure: TOETVA

Interventions

TOETVAPROCEDURE

Transoral Endoscopic Thyroidectomy Vestibular Approach

TOETVA

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Patients needing surgery for: Benign or indeterminate nodule less than 6 cm in size or; T1 well differentiated papillary carcinoma less than 2 cm in size or; Well-controlled Grave's disease or; Parathyroid adenoma.
  • Total thyroid size is 7-8 cm (no more than 10 cm)
  • Their age is ≥18 years and ≤80 years
  • Able to give written consent

You may not qualify if:

  • \- History of neck surgery or neck radiotherapy
  • Recurrent thyroid disease
  • Lymph node metastases
  • Presence of intraoral infections
  • Presence of extrathyroidal or substernal extensions
  • Smoking
  • Morbid obesity
  • Contra-indication to general anesthesia with nasotracheal intubation
  • Previous mediastinal surgery
  • Any anatomical anomaly that in the opinion of the investigator may render the intervention more difficult (ex. variations in the structure of the platysmas muscle)
  • Any medical condition, which in the judgment of the investigator and/or designee makes the subject a poor candidate for the investigational procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Univeristy Health Network

Toronto, Ontario, M5G2C4, Canada

RECRUITING

MeSH Terms

Conditions

Thyroid Diseases

Condition Hierarchy (Ancestors)

Endocrine System Diseases

Study Officials

  • Jesse D Pasternak, MD

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jesse D Pasternak, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: The study intervention in this study is the TOETVA-procedure. This is an Transoral Endoscopic Thyroidectomy Vestibular Approach.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 19, 2021

First Posted

April 13, 2021

Study Start

December 1, 2019

Primary Completion

December 1, 2021

Study Completion

July 1, 2022

Last Updated

April 13, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations